Panel Discussion: Setting Up Context: Capitalizing on the Current Wave of Inhaled Delivery
Time: 9:00 am
day: Conference Day 1
Details:
With renewed interest sparked by COVID-19, unmet clinical needs and better formulation technologies, inhaled
delivery offers key advantages over other routes of administration for targeted local delivery. In this panel
discussion, experts will explore:
- Reflecting on COVID-19, renewed interest and novel technologies
- Formulating biologics for inhaled delivery such as mRNA
- Discussing advantages of inhalation to overcome systemic toxicity issues with bypass of the liver
